Keywords: Diagnosis/Prediction, Tumors, Glioma,Radiomics,Machine Learning
Motivation: Intratumoral heterogeneity is a crucial feature of gliomas, and its potential to aid in molecular subtyping and disease prediction warrants further investigation.
Goal(s): To develop a radiomics model that predicts glioma molecular biomarkers by studying subregions, thereby improving understanding and treatment.
Approach: A retrospective study employing machine learning on MRI data from 316 glioma patients to predict WHO classification, IDH mutation status, and 1p/19q co-deletion status through radiomics feature extraction.
Results: Support Vector Machine (SVM) predicted 1p/19q status in the edema region, while Random Forest (RF) effectively predict IDH status in both the edema and enhancing region.
Impact: Our study predicts biomarkers using glioma subregion radiomics and machine learning , enabling physicians to personalize treatment non-invasively. This approach will inspire other researchers to validate larger datasets and incorporate clinical genetic data.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords